Indication
Parkinson Disease Dementia
2 clinical trials
3 products
Product
ATH-1017Clinical trial
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy BodiesStatus: Completed, Estimated PCD: 2023-04-19
Product
PlaceboClinical trial
Cholinergic Neurotransmission - A Common Underlying Mechanism of Cognitive and Gait Impairment in Parkinson DiseaseStatus: Completed, Estimated PCD: 2020-04-01
Product
Rivastigmine